^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
FZ-AD004
i
Other names: FZ-AD004, Trop2-BB05 ADC, F0040
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Shanghai Fudan-Zhangjiang
Drug class:
Topoisomerase I inhibitor, TROP-2-targeted antibody-drug conjugate
Related drugs:
11ms
A Study of FZ-AD004 in Patients With Advanced Solid Tumors (clinicaltrials.gov)
P1, N=121, Not yet recruiting, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
New P1 trial • Metastases
|
FZ-AD004
Share via
